Citation: Vl. Dawson et Tm. Dawson, Role of poly(ADP-ribose) polymerase mediating acute and chronic neuronal injury and neurodegeneration, PHARM TOXIC, 2000, pp. 23-39
Citation: V. Burkart, Role of poly(ADP-ribose) polymerase in the pathogenesis of pancreatic islet cell death and type 1 diabetes, PHARM TOXIC, 2000, pp. 103-129
Citation: L. Virag, Poly(ADP-ribose) polymerase in the immune system: Focus on reactive nitrogen intermediates and cell death, PHARM TOXIC, 2000, pp. 131-166
Authors:
Sumegi, B
Rabloczky, G
Racz, I
Tory, K
Bernath, S
Varbiro, G
Gallyas, F
Nagy, PL
Citation: B. Sumegi et al., Protective effect of poly(ADP-ribose) polymerase inhibitors against cell damage induced by antiviral and anticancer drugs, PHARM TOXIC, 2000, pp. 167-182
Authors:
Rosenthal, DS
Simbulan-Rosenthal, CM
Smith, WJ
Benton, BJ
Ray, R
Smulson, ME
Citation: Ds. Rosenthal et al., Poly(ADP-ribose) polymerase is an active participant in programmed cell death and maintenance of genomic stability, PHARM TOXIC, 2000, pp. 227-249